Zsolt Harsanyi, Director at Emergent BioSolutions Inc. (EBS), sold 1,927 shares at $15.01 ($29K) on 2009-06-10, disclosed to the SEC on 2009-06-12.
Scheduled sale ($29k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 807 | $12K | 41.7% |
| 2 | $15.01 | 337 | $5K | 17.4% |
| 3 | $15.01 | 130 | $2K | 6.7% |
| 4 | $15.02 | 36 | $541 | 1.9% |
| 5 | $15.03 | 47 | $706 | 2.4% |
| 6 | $15.05 | 36 |
| $542 |
| 1.9% |
| 7 | $15.06 | 107 | $2K | 5.6% |
| 8 | $15.09 | 12 | $181 | 0.6% |
| 9 | $15.12 | 12 | $181 | 0.6% |
| 10 | $15.16 | 59 | $894 | 3.1% |
| 11 | $15.23 | 24 | $366 | 1.3% |
| 12 | $15.26 | 12 | $183 | 0.6% |
| 13 | $15.27 | 118 | $2K | 6.2% |
| 14 | $15.29 | 107 | $2K | 5.6% |
| 15 | $15.31 | 83 | $1K | 4.4% |
| Total | $15.06 avg | 1,927 | $29K | 100% |
| Filing → |
| EBS | SELL | 2020-03-17 | $416K | — | Filing → |
| EBS | SELL | 2020-01-17 | $189K | — | Filing → |
| APVO | BUY | 2019-06-07 | $39K | — | Filing → |